Cargando…
Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine
The aim of the present study was to delineate the therapeutic effect of a Helicobacter pylori vaccine with chitosan as an adjuvant, as well as to identify the potential mechanism against H. pylori infection when compared with an H. pylori vaccine, with cholera toxin (CT) as an adjuvant. Mice were fi...
Autores principales: | GONG, YANFENG, TAO, LIMING, WANG, FUCAI, LIU, WEI, JING, LEI, LIU, DONGSHENG, HU, SIJUN, XIE, YONG, ZHOU, NANJIN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526086/ https://www.ncbi.nlm.nih.gov/pubmed/26095723 http://dx.doi.org/10.3892/mmr.2015.3950 |
Ejemplares similares
-
Association of TLR4 and Treg in Helicobacter pylori Colonization and Inflammation in Mice
por: Gong, Yanfeng, et al.
Publicado: (2016) -
Efficacy and safety of probiotics as adjuvant agents for Helicobacter pylori infection: A meta-analysis
por: LV, ZHIFA, et al.
Publicado: (2015) -
Refractory Helicobacter pylori infection and the gastric microbiota
por: Liu, Dongsheng, et al.
Publicado: (2022) -
Outer Membrane Vesicles of Helicobacter pylori 7.13 as Adjuvants Promote Protective Efficacy Against Helicobacter pylori Infection
por: Song, Zifan, et al.
Publicado: (2020) -
Helicobacter pylori: therapeutic targets.
por: Louw, J. A., et al.
Publicado: (1998)